首页 > 最新文献

Clinical Neurology and Neurosurgery最新文献

英文 中文
Reply to: Correspondence on “Upper respiratory tract infections in myasthenia gravis: Key considerations and future research directions” 复函:《重症肌无力患者上呼吸道感染:重点考虑及未来研究方向》
IF 1.8 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.clineuro.2025.108746
Hussain M. Alqahtani, Mohammed H. Alanazy
{"title":"Reply to: Correspondence on “Upper respiratory tract infections in myasthenia gravis: Key considerations and future research directions”","authors":"Hussain M. Alqahtani, Mohammed H. Alanazy","doi":"10.1016/j.clineuro.2025.108746","DOIUrl":"10.1016/j.clineuro.2025.108746","url":null,"abstract":"","PeriodicalId":10385,"journal":{"name":"Clinical Neurology and Neurosurgery","volume":"249 ","pages":"Article 108746"},"PeriodicalIF":1.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143001199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and validation of a risk stratification model for stroke recurrence after acute ischemic stroke in young adults: A nomogram-based, multicenter retrospective study
IF 1.8 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.clineuro.2025.108763
Zhongzhen Li , Tian Tian , Yujia Yan , Yue Yu , Jun Liu , Shusheng Zhang , Guobin Zhang , Shaoya Yin

Objective

The prevalence of ischemic stroke in young adults has increased dramatically. However, factors associated with prognosis in this cohort have not been well studied. This study primary aimed to construct and validate a nomogram for predicting stroke recurrence and to achieve risk stratification of young adults after acute ischemic stroke (AIS).

Methods

In this retrospective, multicenter study, we identified AIS patients aged 18–50 years in Tianjin Huanhu Hospital (training cohort) and The Affiliated Hospital of Chengde Medical College (validation cohort) from September 2019 to September 2021, respectively. Demographics and clinical characteristics data were systematically collected. A stepwise Cox proportional hazards regression analysis was used to identify the independent predictors of stroke recurrence in the training cohort and employed to construct the best-fit nomogram. Patients were stratified into low-, medium-, and high-risk groups based on the total points. Receiver operating characteristic (ROC) analysis and calibration curves were used to assess the discrimination and calibration of the nomogram. The discriminate value of risk stratification was verified using Kaplan-Meier curves, and external validation was performed with the validation cohort.

Results

A total of 467 young adult AIS patients were enrolled in this study. The overall prevalence of young adults in AIS patients was 13.3 % (95 % confidence interval, 12.2 %-14.5 %). Hyperlipidemia (Hazard ratio, 2.4 [1.2–4.9]), current smoking (5.9 [2.7–12.8]), stroke subtype (small-vessel occlusion, 3.7 [1.8–7.6]; stroke of undetermined cause/ others, 14.5 [3.0–70.2]), and stenosis (11.4 [4.5–28.9]) were significant independent predictors of stroke recurrence. A nomogram was constructed with the above predictors and achieved a satisfactory prediction in the validation cohort. Patients were classified into low-, medium-, and high-risk groups based on the total points with the cutoff value of 110.8 and 185.2. The log-rank test showed significant discrimination among the Kaplan-Meier curves of different risk groups (P < 0.001).

Conclusion

The nomogram can satisfactory prediction of stroke recurrence-free rate in young adult patients and achieved risk stratification, may help to personalize management of patients.
{"title":"Development and validation of a risk stratification model for stroke recurrence after acute ischemic stroke in young adults: A nomogram-based, multicenter retrospective study","authors":"Zhongzhen Li ,&nbsp;Tian Tian ,&nbsp;Yujia Yan ,&nbsp;Yue Yu ,&nbsp;Jun Liu ,&nbsp;Shusheng Zhang ,&nbsp;Guobin Zhang ,&nbsp;Shaoya Yin","doi":"10.1016/j.clineuro.2025.108763","DOIUrl":"10.1016/j.clineuro.2025.108763","url":null,"abstract":"<div><h3>Objective</h3><div>The prevalence of ischemic stroke in young adults has increased dramatically. However, factors associated with prognosis in this cohort have not been well studied. This study primary aimed to construct and validate a nomogram for predicting stroke recurrence and to achieve risk stratification of young adults after acute ischemic stroke (AIS).</div></div><div><h3>Methods</h3><div>In this retrospective, multicenter study, we identified AIS patients aged 18–50 years in Tianjin Huanhu Hospital (training cohort) and The Affiliated Hospital of Chengde Medical College (validation cohort) from September 2019 to September 2021, respectively. Demographics and clinical characteristics data were systematically collected. A stepwise Cox proportional hazards regression analysis was used to identify the independent predictors of stroke recurrence in the training cohort and employed to construct the best-fit nomogram. Patients were stratified into low-, medium-, and high-risk groups based on the total points. Receiver operating characteristic (ROC) analysis and calibration curves were used to assess the discrimination and calibration of the nomogram. The discriminate value of risk stratification was verified using Kaplan-Meier curves, and external validation was performed with the validation cohort.</div></div><div><h3>Results</h3><div>A total of 467 young adult AIS patients were enrolled in this study. The overall prevalence of young adults in AIS patients was 13.3 % (95 % confidence interval, 12.2 %-14.5 %). Hyperlipidemia (Hazard ratio, 2.4 [1.2–4.9]), current smoking (5.9 [2.7–12.8]), stroke subtype (small-vessel occlusion, 3.7 [1.8–7.6]; stroke of undetermined cause/ others, 14.5 [3.0–70.2]), and stenosis (11.4 [4.5–28.9]) were significant independent predictors of stroke recurrence. A nomogram was constructed with the above predictors and achieved a satisfactory prediction in the validation cohort. Patients were classified into low-, medium-, and high-risk groups based on the total points with the cutoff value of 110.8 and 185.2. The log-rank test showed significant discrimination among the Kaplan-Meier curves of different risk groups (<em>P</em> &lt; 0.001).</div></div><div><h3>Conclusion</h3><div>The nomogram can satisfactory prediction of stroke recurrence-free rate in young adult patients and achieved risk stratification, may help to personalize management of patients.</div></div>","PeriodicalId":10385,"journal":{"name":"Clinical Neurology and Neurosurgery","volume":"249 ","pages":"Article 108763"},"PeriodicalIF":1.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143051666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical outcomes of percutaneous treatments for trigeminal neuralgia in multiple sclerosis: A reassessment of insights and concerns.
IF 1.8 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 Epub Date: 2025-02-13 DOI: 10.1016/j.clineuro.2025.108780
Hung Youl Seok
{"title":"Clinical outcomes of percutaneous treatments for trigeminal neuralgia in multiple sclerosis: A reassessment of insights and concerns.","authors":"Hung Youl Seok","doi":"10.1016/j.clineuro.2025.108780","DOIUrl":"10.1016/j.clineuro.2025.108780","url":null,"abstract":"","PeriodicalId":10385,"journal":{"name":"Clinical Neurology and Neurosurgery","volume":"249 ","pages":"108780"},"PeriodicalIF":1.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143432409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparative analysis of microsurgical resection versus stereotactic radiosurgery for Spetzler-Martin grade III arteriovenous malformations: A multicenter propensity score matched study 显微外科切除与立体定向放射手术治疗Spetzler-Martin III级动静脉畸形的比较分析:一项多中心倾向评分匹配研究。
IF 1.8 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.clineuro.2024.108669
Salem M. Tos , Bardia Hajikarimloo , Mahmoud Osama , Georgios Mantziaris , Nimer Adeeb , Sandeep Kandregula , Hamza Adel Salim , Basel Musmar , Christopher Ogilvy , Douglas Kondziolka , Adam A. Dmytriw , Kareem El Naamani , Ahmed Abdelsalam , Deepak Kumbhare , Sanjeev Gummadi , Cagdas Ataoglu , Muhammed Amir Essibayi , Ufuk Erginoglu , Abdullah Keles , Sandeep Muram , Jason Sheehan

Background

Spetzler-Martin (SM) Grade III brain arteriovenous malformations (BAVMs) represent a transitional risk zone between low- and high-grade BAVMs, characterized by diverse angioarchitecture. The primary treatment options are endovascular embolization, microsurgical resection (MS), and stereotactic radiosurgery (SRS). This study compares the efficacy and outcomes of MS and SRS.

Methods

We conducted a multicenter, retrospective study involving patients from the MISTA database with SM Grade III BAVMs treated with MS or SRS between 2010 and 2023. Propensity matching was based on age, favorable modified Rankin Score (mRS) at presentation, nidus size, rupture status, location depth, and eloquence.

Results

After matching, 60 patients were equally divided between MS and SRS groups. Median age (MS: 45.0 vs. SRS: 42.5 years, p = 0.3) and AVM size (MS: 3.2 vs. SRS: 2.9 cm3, p = 0.6) were similar. MS showed higher obliteration rates (93.3 %) compared to SRS (46.7 %) at the last follow-up (p < 0.001). The median time to obliteration post-SRS was 31.5 months (IQR: 15.3–60.0). SRS obliteration rates were 19 %, 29 %, and 59 % at 24, 36, and 60 months, respectively. Overall complication rates (MS: 30 % vs. SRS: 20 %, p = 0.4) and permanent complications (MS: 10 % vs. SRS: 13.3 %, p > 0.9) were similar. Hemorrhage occurred once in the MS group and none in the SRS (p > 0.9). Favorable outcomes (mRS 0–2) were higher with SRS than MS (93.3 % vs 80.0 %, p = 0.3), with one AVM-related mortality in the MS group.

Conclusion

MS and SRS are viable treatments for SM Grade III BAVMs. Treatment choice should be individualized by a multidisciplinary team, considering patient goals.
背景:Spetzler-Martin (SM) III级脑动静脉畸形(BAVMs)是介于低级别和高级别之间的过渡性危险区域,其特征是血管结构多样。主要的治疗选择是血管内栓塞、显微外科切除(MS)和立体定向放射外科(SRS)。本研究比较了MS和SRS的疗效和结果。方法:我们进行了一项多中心回顾性研究,纳入了MISTA数据库中2010年至2023年间接受MS或SRS治疗的SM III级BAVMs患者。倾向匹配基于年龄、表现时良好的修正Rankin评分(mRS)、病灶大小、破裂状态、定位深度和口才。结果:经配对后,60例患者平均分为MS组和SRS组。中位年龄(MS: 45.0 vs. SRS: 42.5岁,p = 0.3)和AVM大小(MS: 3.2 vs. SRS: 2.9 cm3, p = 0.6)相似。最后一次随访时,MS组的闭塞率(93.3 %)高于SRS组(46.7 %)(p  0.9)。MS组出血1次,SRS组无出血(p > 0.9)。SRS组的有利结果(mRS 0-2)高于MS组(93.3 % vs 80.0 %,p = 0.3),MS组有1例avm相关死亡率。结论:MS和SRS治疗SM III级BAVMs是可行的治疗方法。治疗选择应由多学科团队根据患者的目标进行个体化。
{"title":"A comparative analysis of microsurgical resection versus stereotactic radiosurgery for Spetzler-Martin grade III arteriovenous malformations: A multicenter propensity score matched study","authors":"Salem M. Tos ,&nbsp;Bardia Hajikarimloo ,&nbsp;Mahmoud Osama ,&nbsp;Georgios Mantziaris ,&nbsp;Nimer Adeeb ,&nbsp;Sandeep Kandregula ,&nbsp;Hamza Adel Salim ,&nbsp;Basel Musmar ,&nbsp;Christopher Ogilvy ,&nbsp;Douglas Kondziolka ,&nbsp;Adam A. Dmytriw ,&nbsp;Kareem El Naamani ,&nbsp;Ahmed Abdelsalam ,&nbsp;Deepak Kumbhare ,&nbsp;Sanjeev Gummadi ,&nbsp;Cagdas Ataoglu ,&nbsp;Muhammed Amir Essibayi ,&nbsp;Ufuk Erginoglu ,&nbsp;Abdullah Keles ,&nbsp;Sandeep Muram ,&nbsp;Jason Sheehan","doi":"10.1016/j.clineuro.2024.108669","DOIUrl":"10.1016/j.clineuro.2024.108669","url":null,"abstract":"<div><h3>Background</h3><div>Spetzler-Martin (SM) Grade III brain arteriovenous malformations (BAVMs) represent a transitional risk zone between low- and high-grade BAVMs, characterized by diverse angioarchitecture. The primary treatment options are endovascular embolization, microsurgical resection (MS), and stereotactic radiosurgery (SRS). This study compares the efficacy and outcomes of MS and SRS.</div></div><div><h3>Methods</h3><div>We conducted a multicenter, retrospective study involving patients from the MISTA database with SM Grade III BAVMs treated with MS or SRS between 2010 and 2023. Propensity matching was based on age, favorable modified Rankin Score (mRS) at presentation, nidus size, rupture status, location depth, and eloquence.</div></div><div><h3>Results</h3><div>After matching, 60 patients were equally divided between MS and SRS groups. Median age (MS: 45.0 vs. SRS: 42.5 years, p = 0.3) and AVM size (MS: 3.2 vs. SRS: 2.9 cm<sup>3</sup>, p = 0.6) were similar. MS showed higher obliteration rates (93.3 %) compared to SRS (46.7 %) at the last follow-up (p &lt; 0.001). The median time to obliteration post-SRS was 31.5 months (IQR: 15.3–60.0). SRS obliteration rates were 19 %, 29 %, and 59 % at 24, 36, and 60 months, respectively. Overall complication rates (MS: 30 % vs. SRS: 20 %, p = 0.4) and permanent complications (MS: 10 % vs. SRS: 13.3 %, p &gt; 0.9) were similar. Hemorrhage occurred once in the MS group and none in the SRS (p &gt; 0.9). Favorable outcomes (mRS 0–2) were higher with SRS than MS (93.3 % vs 80.0 %, p = 0.3), with one AVM-related mortality in the MS group.</div></div><div><h3>Conclusion</h3><div>MS and SRS are viable treatments for SM Grade III BAVMs. Treatment choice should be individualized by a multidisciplinary team, considering patient goals.</div></div>","PeriodicalId":10385,"journal":{"name":"Clinical Neurology and Neurosurgery","volume":"249 ","pages":"Article 108669"},"PeriodicalIF":1.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142790688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current evidence of arterial spin labeling in amyotrophic lateral sclerosis: A systematic review 肌萎缩性脊髓侧索硬化症动脉自旋标记的现有证据:系统综述。
IF 1.8 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.clineuro.2024.108691
Sadegh Ghaderi , Sana Mohammadi , Farzad Fatehi

Objective

This study aimed to evaluate the utility of arterial spin labeling (ASL) in assessing cerebral blood flow (CBF) changes in amyotrophic lateral sclerosis (ALS), and its potential as a biomarker for early diagnosis.

Methods

A systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies that employed ASL to compare CBF between ALS patients and healthy controls were included.

Results

Seven studies were included. A consistent finding across these studies was hypoperfusion in both the motor and non-motor regions, particularly in the frontotemporal cortex. Hypoperfusion in motor regions was correlated with functional impairment and was observed prior to structural changes, suggesting its potential as an early biomarker. There is limited evidence to suggest that monitoring changes in CBF patterns in the brain. Besides, limited findings showed initial hyperperfusion in regions not yet involved in the pathological process, and progressing hypoperfusion in regions with increasing pathological burden.

Conclusions

This review highlights the potential of ASL as a valuable tool for understanding the neurovascular dysfunction in ALS. Further research is required to validate its clinical utility for diagnosing ALS and monitoring disease progression.
目的:本研究旨在评估动脉自旋标记(ASL)在评估肌萎缩性侧索硬化症(ALS)患者脑血流量(CBF)变化中的作用,及其作为早期诊断生物标志物的潜力。方法:按照系统评价和荟萃分析指南的首选报告项目进行系统评价。采用ASL比较ALS患者和健康对照的CBF的研究也包括在内。结果:纳入7项研究。这些研究的一致发现是运动区和非运动区,特别是额颞叶皮层的灌注不足。运动区域的低灌注与功能损伤相关,并且在结构改变之前被观察到,这表明其作为早期生物标志物的潜力。有有限的证据表明监测脑CBF模式的变化在大脑中。此外,有限的研究结果显示,在尚未参与病理过程的区域出现初始高灌注,在病理负担增加的区域出现进行性低灌注。结论:本综述强调了肌萎缩侧索硬化症作为了解肌萎缩侧索硬化症神经血管功能障碍的有价值工具的潜力。需要进一步的研究来验证其在诊断ALS和监测疾病进展方面的临床应用。
{"title":"Current evidence of arterial spin labeling in amyotrophic lateral sclerosis: A systematic review","authors":"Sadegh Ghaderi ,&nbsp;Sana Mohammadi ,&nbsp;Farzad Fatehi","doi":"10.1016/j.clineuro.2024.108691","DOIUrl":"10.1016/j.clineuro.2024.108691","url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to evaluate the utility of arterial spin labeling (ASL) in assessing cerebral blood flow (CBF) changes in amyotrophic lateral sclerosis (ALS), and its potential as a biomarker for early diagnosis.</div></div><div><h3>Methods</h3><div>A systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies that employed ASL to compare CBF between ALS patients and healthy controls were included.</div></div><div><h3>Results</h3><div>Seven studies were included. A consistent finding across these studies was hypoperfusion in both the motor and non-motor regions, particularly in the frontotemporal cortex. Hypoperfusion in motor regions was correlated with functional impairment and was observed prior to structural changes, suggesting its potential as an early biomarker. There is limited evidence to suggest that monitoring changes in CBF patterns in the brain. Besides, limited findings showed initial hyperperfusion in regions not yet involved in the pathological process, and progressing hypoperfusion in regions with increasing pathological burden.</div></div><div><h3>Conclusions</h3><div>This review highlights the potential of ASL as a valuable tool for understanding the neurovascular dysfunction in ALS. Further research is required to validate its clinical utility for diagnosing ALS and monitoring disease progression.</div></div>","PeriodicalId":10385,"journal":{"name":"Clinical Neurology and Neurosurgery","volume":"249 ","pages":"Article 108691"},"PeriodicalIF":1.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142863362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence and associated in-hospital mortality of myocardial injury in patients with traumatic brain injury: A systematic review and meta-analysis 外伤性脑损伤患者心肌损伤的发生率和相关住院死亡率:一项系统回顾和荟萃分析
IF 1.8 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.clineuro.2024.108693
Huaqiang Ding, Xiaofeng Hou, Xinhai Zhang, Jinhui Yu, Jun He, Jiuning Tang, Minruo Chen, Maoyuan Tang, Qifu Ren, Zhi Liu

Objective

Myocardial injury has not been well characterized in traumatic brain injury (TBI). We aimed to assess the pooled incidence of myocardial injury defined by elevated cardiac troponin (cTn) after TBI and explore its association with in-hospital mortality.

Methods

We searched Medline, Embase, Cochrane Library, Scopus, and Web of Science from inception to 1 January 2024, for observational studies that assessed the incidence and/or associated in-hospital mortality of elevated cTn in adult TBI patients. The incidence data was reported with proportion with 95 % confidence intervals (CIs) and 95 % prediction intervals (PIs). In-hospital mortality data was synthesized with odds ratios (ORs) with 95 % CIs and 95 % PIs. Subgroup analyses and meta-regression analyses were performed to identify the potential sources of heterogeneity, and the leave-one-out method was performed for sensitivity analysis.

Results

We included 16 studies involving 4263 participants in the meta-analysis. The overall pooled incidence of myocardial injury after TBI was 33.3 % (95 % CI, 25.2 %–42.1 %; 95 % PI, 7.3 %-66.7 %; I2 = 95.3 %). Incidence of myocardial injury was 43.4 % (95 % CI, 31.7 %–55.4 %; 95 % PI 7.3 %-84.1 %; I2 = 94.8 %) for moderate to severe TBI. Myocardial injury was associated with higher in-hospital mortality (OR, 5.62; 95 % CI, 3.59–8.78; 95 % PI, 1.35–23.38; I2 = 79.0 %) after TBI.

Conclusion

Early myocardial injury was common in adult patients with acute TBI. Furthermore, myocardial injury was associated with increased in-hospital mortality after TBI. High-quality studies are needed to elucidate the true incidence of myocardial injury and its relationship between clinical outcomes in this populations.
目的:外伤性脑损伤(TBI)的心肌损伤特征尚不明确。我们的目的是评估脑外伤后心肌肌钙蛋白(cTn)升高所定义的心肌损伤的总发生率,并探讨其与住院死亡率的关系。方法:我们检索了Medline, Embase, Cochrane Library, Scopus和Web of Science从成立到2024年1月1日的观察性研究,以评估成人TBI患者cTn升高的发生率和/或相关的住院死亡率。发病率数据以95% %置信区间(ci)和95% %预测区间(pi)的比例报告。采用95% % ci和95% % pi的优势比(or)综合住院死亡率数据。采用亚组分析和meta回归分析来确定潜在的异质性来源,并采用留一法进行敏感性分析。结果:我们在meta分析中纳入了16项研究,涉及4263名参与者。TBI后心肌损伤的总合并发生率为33.3% %(95 % CI, 25.2 %-42.1 %;95 % pi, 7.3 %-66.7 %;I2 = 95.3 %)。心肌损伤发生率为43.4% %(95% % CI, 31.7% %- 55.4% %;95 % PI 7.3 %-84.1 %;I2 = 94.8 %)为中重度TBI。心肌损伤与较高的住院死亡率相关(OR, 5.62;95 % ci, 3.59-8.78;95 % pi, 1.35-23.38;I2 = 79.0 %)。结论:成年急性脑外伤患者早期心肌损伤较为常见。此外,心肌损伤与脑外伤后住院死亡率增加有关。需要高质量的研究来阐明这一人群中心肌损伤的真实发生率及其与临床结果的关系。
{"title":"Incidence and associated in-hospital mortality of myocardial injury in patients with traumatic brain injury: A systematic review and meta-analysis","authors":"Huaqiang Ding,&nbsp;Xiaofeng Hou,&nbsp;Xinhai Zhang,&nbsp;Jinhui Yu,&nbsp;Jun He,&nbsp;Jiuning Tang,&nbsp;Minruo Chen,&nbsp;Maoyuan Tang,&nbsp;Qifu Ren,&nbsp;Zhi Liu","doi":"10.1016/j.clineuro.2024.108693","DOIUrl":"10.1016/j.clineuro.2024.108693","url":null,"abstract":"<div><h3>Objective</h3><div>Myocardial injury has not been well characterized in traumatic brain injury (TBI). We aimed to assess the pooled incidence of myocardial injury defined by elevated cardiac troponin (cTn) after TBI and explore its association with in-hospital mortality.</div></div><div><h3>Methods</h3><div>We searched Medline, Embase, Cochrane Library, Scopus, and Web of Science from inception to 1 January 2024, for observational studies that assessed the incidence and/or associated in-hospital mortality of elevated cTn in adult TBI patients. The incidence data was reported with proportion with 95 % confidence intervals (CIs) and 95 % prediction intervals (PIs). In-hospital mortality data was synthesized with odds ratios (ORs) with 95 % CIs and 95 % PIs. Subgroup analyses and meta-regression analyses were performed to identify the potential sources of heterogeneity, and the leave-one-out method was performed for sensitivity analysis.</div></div><div><h3>Results</h3><div>We included 16 studies involving 4263 participants in the meta-analysis. The overall pooled incidence of myocardial injury after TBI was 33.3 % (95 % CI, 25.2 %–42.1 %; 95 % PI, 7.3 %-66.7 %; I2 = 95.3 %). Incidence of myocardial injury was 43.4 % (95 % CI, 31.7 %–55.4 %; 95 % PI 7.3 %-84.1 %; I2 = 94.8 %) for moderate to severe TBI. Myocardial injury was associated with higher in-hospital mortality (OR, 5.62; 95 % CI, 3.59–8.78; 95 % PI, 1.35–23.38; I2 = 79.0 %) after TBI.</div></div><div><h3>Conclusion</h3><div>Early myocardial injury was common in adult patients with acute TBI. Furthermore, myocardial injury was associated with increased in-hospital mortality after TBI. High-quality studies are needed to elucidate the true incidence of myocardial injury and its relationship between clinical outcomes in this populations.</div></div>","PeriodicalId":10385,"journal":{"name":"Clinical Neurology and Neurosurgery","volume":"249 ","pages":"Article 108693"},"PeriodicalIF":1.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of prior use of statins on endovascular thrombectomy outcomes in acute ischemic stroke 既往使用他汀类药物对急性缺血性卒中血管内血栓切除术结果的影响。
IF 1.8 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.clineuro.2025.108724
Nader El Seblani , Saurabh Kalra , Deepak Kalra , Fawaz Al-Mufti , Nandakumar Nagaraja

Introduction

Acute large vessel occlusions (LVOs) account for up to one-third of acute ischemic strokes (AIS) and are associated with high mortality and severe functional deficits. Animal model research suggests that statins may have a protective effect on vessel wall injury during endovascular thrombectomy (EVT). We conducted a retrospective observational study to assess the impact of statin use on clinical outcomes post-EVT in AIS patients with LVOs.

Methods

Using the Global Collaborative Network consisting of about 143 million patients in TriNetX database, we identified adult AIS patients who underwent EVT between 2018 and 2023. Patients were categorized based on any statin use (atorvastatin, simvastatin, rosuvastatin, pravastatin, lovastatin, or pitavastatin) in the 3 months before AIS admission. The primary outcome was all-cause mortality at one-week post-EVT. Secondary outcomes included intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), decompressive hemicraniectomy procedure (DHC), and aspiration pneumonia at one-week post-EVT. Propensity score matching balanced relevant medical history, stroke severity, medications, and demographics. Cox proportional hazard regression analysis compared outcomes between statin and non-statin cohorts.

Results

We identified 17,774 patients who received EVT for LVO ischemic stroke. A total of 10,678 patients were on statins during 3 months prior to EVT and 7096 patients were not on statins. After 1:1 propensity matching, 2148 patients were included in each group. AIS patients treated with EVT and on statins had lower risk of all-cause mortality [7 % vs. 17 %; HR 0.43, 95 % CI 0.35–0.51], ICH [10 % vs. 15 %; HR 0.64, 95 % CI 0.51–0.74], SAH [3 % vs. 6 %; HR 0.48, 95 % CI 0.35–0.64], and aspiration pneumonia [4 % vs 8 %; HR 0.53, 95 % CI 0.41–0.70] compared to AIS patients treated with EVT but not on statins. Rates of DHC were similar between groups [2 % vs 2 %; HR 0.81; 95 % CI (0.52,1.25)].

Conclusion

Statin use within 3 months prior to AIS was associated with better survival and lesser intracranial bleeding risks and complications following EVT. Future studies may help examine how the duration or dosages of statins or LDL levels on admission affect outcomes in LVO strokes treated with EVT.
简介:急性大血管闭塞(LVOs)占急性缺血性中风(AIS)的三分之一,并与高死亡率和严重的功能缺陷相关。动物模型研究表明,他汀类药物可能对血管内取栓(EVT)过程中血管壁损伤有保护作用。我们进行了一项回顾性观察性研究,以评估他汀类药物对AIS合并lvo患者evt后临床结果的影响。方法:利用TriNetX数据库中约1.43亿患者组成的全球协作网络,我们确定了2018年至2023年间接受EVT的成年AIS患者。患者在AIS入院前3个月内根据他汀类药物的使用情况(阿托伐他汀、辛伐他汀、瑞舒伐他汀、普伐他汀、洛伐他汀或匹伐他汀)进行分类。主要终点是evt后一周的全因死亡率。继发性结局包括脑出血(ICH)、蛛网膜下腔出血(SAH)、减压半骨切除术(DHC)和evt后一周吸入性肺炎。倾向评分匹配平衡了相关的病史、中风严重程度、药物和人口统计学。Cox比例风险回归分析比较了他汀类药物和非他汀类药物队列的结果。结果:我们确定了17774例左心室缺血性卒中患者接受EVT治疗。EVT前3个月共有10678名患者服用他汀类药物,7096名患者未服用他汀类药物。经1:1倾向匹配,每组2148例。接受EVT和他汀类药物治疗的AIS患者全因死亡风险较低[7 % vs. 17 %;HR 0.43, 95 % CI 0.35-0.51], ICH[10 %比15 %;HR 0.64, 95 % CI 0.51-0.74], SAH[3 %对6 %;HR 0.48, 95 % CI 0.35-0.64],吸入性肺炎[4 % vs 8 %;HR 0.53, 95 % CI 0.41-0.70]与EVT治疗但不使用他汀类药物的AIS患者相比。两组间DHC发生率相似[2 % vs 2 %;人力资源0.81;95 % ci(0.52,1.25)]。结论:AIS前3个月内使用他汀类药物可提高生存率,减少EVT后颅内出血风险和并发症。未来的研究可能有助于检查入院时他汀类药物的持续时间或剂量或LDL水平如何影响EVT治疗的LVO卒中的结果。
{"title":"Effect of prior use of statins on endovascular thrombectomy outcomes in acute ischemic stroke","authors":"Nader El Seblani ,&nbsp;Saurabh Kalra ,&nbsp;Deepak Kalra ,&nbsp;Fawaz Al-Mufti ,&nbsp;Nandakumar Nagaraja","doi":"10.1016/j.clineuro.2025.108724","DOIUrl":"10.1016/j.clineuro.2025.108724","url":null,"abstract":"<div><h3>Introduction</h3><div>Acute large vessel occlusions (LVOs) account for up to one-third of acute ischemic strokes (AIS) and are associated with high mortality and severe functional deficits. Animal model research suggests that statins may have a protective effect on vessel wall injury during endovascular thrombectomy (EVT). We conducted a retrospective observational study to assess the impact of statin use on clinical outcomes post-EVT in AIS patients with LVOs.</div></div><div><h3>Methods</h3><div>Using the Global Collaborative Network consisting of about 143 million patients in TriNetX database, we identified adult AIS patients who underwent EVT between 2018 and 2023. Patients were categorized based on any statin use (atorvastatin, simvastatin, rosuvastatin, pravastatin, lovastatin, or pitavastatin) in the 3 months before AIS admission. The primary outcome was all-cause mortality at one-week post-EVT. Secondary outcomes included intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), decompressive hemicraniectomy procedure (DHC), and aspiration pneumonia at one-week post-EVT. Propensity score matching balanced relevant medical history, stroke severity, medications, and demographics. Cox proportional hazard regression analysis compared outcomes between statin and non-statin cohorts.</div></div><div><h3>Results</h3><div>We identified 17,774 patients who received EVT for LVO ischemic stroke. A total of 10,678 patients were on statins during 3 months prior to EVT and 7096 patients were not on statins. After 1:1 propensity matching, 2148 patients were included in each group. AIS patients treated with EVT and on statins had lower risk of all-cause mortality [7 % vs. 17 %; HR 0.43, 95 % CI 0.35–0.51], ICH [10 % vs. 15 %; HR 0.64, 95 % CI 0.51–0.74], SAH [3 % vs. 6 %; HR 0.48, 95 % CI 0.35–0.64], and aspiration pneumonia [4 % vs 8 %; HR 0.53, 95 % CI 0.41–0.70] compared to AIS patients treated with EVT but not on statins. Rates of DHC were similar between groups [2 % vs 2 %; HR 0.81; 95 % CI (0.52,1.25)].</div></div><div><h3>Conclusion</h3><div>Statin use within 3 months prior to AIS was associated with better survival and lesser intracranial bleeding risks and complications following EVT. Future studies may help examine how the duration or dosages of statins or LDL levels on admission affect outcomes in LVO strokes treated with EVT.</div></div>","PeriodicalId":10385,"journal":{"name":"Clinical Neurology and Neurosurgery","volume":"249 ","pages":"Article 108724"},"PeriodicalIF":1.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142945796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bridging the gap: A scoping review of endovascular and microsurgical approaches to anterior ethmoidal dural arteriovenous fistulas 弥合差距:筛膜前硬膜动静脉瘘的血管内和显微手术入路的范围回顾。
IF 1.8 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.clineuro.2025.108734
Samantha Schimmel , Emma Dunn , Emma Sargent , Daryl T. Goldman , Elliot Pressman , Waldo Guerrero , Maxim Mokin , Siviero Agazzi , Kunal Vakharia

Introduction

Dural arteriovenous fistulas (dAVF) are abnormal anastomoses between meningeal arteries and dural venous sinuses. Typically, dAVF treatment involves an endovascular or microsurgical approach. Anterior ethmoidal artery (AEA) dAVFs pose unique challenges due to their anatomy and location. We performed a scoping review to characterize pre and postoperative characteristics of AEA dAVFs and elucidate their optimal management.

Methods

The authors conducted a comprehensive literature search on PubMed and Embase using Arskey & O’Malley’s scoping review framework. The search strategy included "anterior," "ethmoidal," and "fistula" and excluded review articles and studies with unrelated pathology. Data collected included patient demographics, presentation, angiographic features, treatment modalities, and clinical and radiological outcomes.

Results

One-hundred and two articles describing 273 patients with an average age of 58.79 years were included. Two-hundred and sixty patients had surgery; 127 (49 %) had endovascular embolization and 133 (51 %) had open surgery. Surgical approach was significantly associated with complete dAVF obliteration (p = 0.003, X2=8.73, N = 206); patients treated endovascularly were less likely to have complete dAVF obliteration (85.9 % for endovascular versus 97.2 % for microsurgery). Additionally, patients with preoperative dAVF rupture had significantly greater rates of postoperative hemorrhage (p = 0.003, X2=11.86, N = 184).

Discussion

Surgical techniques and endovascular embolization are commonly used when treating dAVF, and our results highlight that open surgery appears to be superior to endovascular embolization when considering complete AEA dAVF obliteration. Despite advancements in treatment modalities, complications such as stroke, hemorrhage, and recurrence persist, emphasizing the importance of continued research and refinement of therapeutic strategies.
简介硬脑膜动静脉瘘(dAVF)是脑膜动脉和硬脑膜静脉窦之间的异常吻合。硬脑膜动静脉瘘的治疗通常采用血管内或显微外科方法。前乙状动脉(AEA)硬脑膜窦由于其解剖结构和位置而构成了独特的挑战。我们对 AEA dAVF 的术前和术后特征进行了范围界定,并阐明了其最佳治疗方法:作者采用 Arskey & O'Malley 的范围界定综述框架在 PubMed 和 Embase 上进行了全面的文献检索。搜索策略包括 "前部"、"乙状 "和 "瘘管",并排除了综述文章和与病理无关的研究。收集的数据包括患者的人口统计学特征、发病情况、血管造影特征、治疗方式以及临床和放射学结果:结果:共收录了 122 篇文章,描述了 273 名患者,平均年龄为 58.79 岁。260名患者接受了手术,其中127人(49%)接受了血管内栓塞治疗,133人(51%)接受了开放手术。手术方法与 dAVF 完全阻塞有显著相关性(p = 0.003,X2=8.73,N = 206);接受血管内治疗的患者出现 dAVF 完全阻塞的可能性较低(血管内治疗为 85.9%,显微手术为 97.2%)。此外,术前dAVF破裂的患者术后出血率明显更高(P = 0.003,X2=11.86,N = 184):讨论:外科技术和血管内栓塞是治疗dAVF的常用方法,我们的研究结果表明,在考虑完全阻断AEA dAVF时,开放手术似乎优于血管内栓塞。尽管治疗方法取得了进步,但中风、出血和复发等并发症依然存在,这强调了继续研究和完善治疗策略的重要性。
{"title":"Bridging the gap: A scoping review of endovascular and microsurgical approaches to anterior ethmoidal dural arteriovenous fistulas","authors":"Samantha Schimmel ,&nbsp;Emma Dunn ,&nbsp;Emma Sargent ,&nbsp;Daryl T. Goldman ,&nbsp;Elliot Pressman ,&nbsp;Waldo Guerrero ,&nbsp;Maxim Mokin ,&nbsp;Siviero Agazzi ,&nbsp;Kunal Vakharia","doi":"10.1016/j.clineuro.2025.108734","DOIUrl":"10.1016/j.clineuro.2025.108734","url":null,"abstract":"<div><h3>Introduction</h3><div>Dural arteriovenous fistulas (dAVF) are abnormal anastomoses between meningeal arteries and dural venous sinuses. Typically, dAVF treatment involves an endovascular or microsurgical approach. Anterior ethmoidal artery (AEA) dAVFs pose unique challenges due to their anatomy and location. We performed a scoping review to characterize pre and postoperative characteristics of AEA dAVFs and elucidate their optimal management.</div></div><div><h3>Methods</h3><div>The authors conducted a comprehensive literature search on PubMed and Embase using Arskey &amp; O’Malley’s scoping review framework. The search strategy included \"anterior,\" \"ethmoidal,\" and \"fistula\" and excluded review articles and studies with unrelated pathology. Data collected included patient demographics, presentation, angiographic features, treatment modalities, and clinical and radiological outcomes.</div></div><div><h3>Results</h3><div>One-hundred and two articles describing 273 patients with an average age of 58.79 years were included. Two-hundred and sixty patients had surgery; 127 (49 %) had endovascular embolization and 133 (51 %) had open surgery. Surgical approach was significantly associated with complete dAVF obliteration (p = 0.003, X<sup>2</sup>=8.73, N = 206); patients treated endovascularly were less likely to have complete dAVF obliteration (85.9 % for endovascular versus 97.2 % for microsurgery). Additionally, patients with preoperative dAVF rupture had significantly greater rates of postoperative hemorrhage (p = 0.003, X<sup>2</sup>=11.86, N = 184).</div></div><div><h3>Discussion</h3><div>Surgical techniques and endovascular embolization are commonly used when treating dAVF, and our results highlight that open surgery appears to be superior to endovascular embolization when considering complete AEA dAVF obliteration. Despite advancements in treatment modalities, complications such as stroke, hemorrhage, and recurrence persist, emphasizing the importance of continued research and refinement of therapeutic strategies.</div></div>","PeriodicalId":10385,"journal":{"name":"Clinical Neurology and Neurosurgery","volume":"249 ","pages":"Article 108734"},"PeriodicalIF":1.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142969890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of intravenous tirofiban in patients with acute ischemic stroke due to large artery atherosclerosis undergoing endovascular thrombectomy: A systematic review and meta-analysis 静脉注射替罗非班治疗大动脉粥样硬化急性缺血性卒中血管内取栓术的疗效和安全性:一项系统综述和荟萃分析。
IF 1.8 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.clineuro.2025.108727
Ocílio Ribeiro Gonçalves , Frederico de Sousa Marinho Mendes Filho , Filipe Virgilio Ribeiro , Saul Dominici , Christian Ken Fukunaga , Naysha Myllene de Lima Gonçalves , Kenzo Ogasawara , Rebeca Oliveira da Silva , Kelson James Almeida

Introduction

Intravenous tirofiban (IT) is shown to be potentially effective in acute ischemic stroke (AIS) patients submitted to mechanical thrombectomy, despite its safety and efficacy are not well established. However, there is a lack of evidence on the effects of IT on endovascular thrombectomy (EVT) in patients with AIS due to large artery atherosclerosis (LAA).

Objectives

To assess the safety and efficacy of IT in AIS patients due to LAA submitted to EVT.

Methods

Pubmed, Embase, Cochrane Central Register of Controlled Trials, and Web of Science databases were systematically searched for studies that involved patients enrolled to take IT in AIS caused by LAA. The statistical analysis was performed using Risk Ratio (RR) with 95 % confidence intervals and the Mantel-Haenszel method of random-effects model to evaluate both efficacy and safety. Heterogeneity was assessed using I² statistics and Cochran Q test. This meta-analysis evaluated a modified Rankin scale (mRS) between 0 and 2, successful reperfusion, symptomatic intracranial hemorrhage (sICH), and mortality in 90 days. The statistical analyses for this study were performed using R software (version 4.4.1.)

Results

A total of 8 studies were analyzed, and a total of 2607 patients were included. In the meta-analysis, the IT group was associated with a higher proportion of patients in mRS 0–2 (RR 1.16; 95 % CI 1.04–1.29; I² = 0 %). There was no difference between the groups regarding successful reperfusion (RR 1.03; 95 % CI 0.98–1.09; I² = 64.2 %) and sICH (RR 0.83; 95 % CI 0.55–1.26; I² = 22.9 %), although tirofiban was associated with a lower mortality in 90 days (RR 0.70; 95 % CI 0.60–0.82; I² = 0 %).

Conclusion

This meta-analysis highlights the positive effects of adjuvant IT for AIS patients due to LAA submitted to EVT. It has been shown to improve functional outcomes and lower mortality rates in this population and to be a reliable medication in this setting.
静脉注射替罗非班(IT)被证明对接受机械取栓的急性缺血性卒中(AIS)患者有潜在的疗效,尽管其安全性和有效性尚未得到很好的证实。然而,IT对大动脉粥样硬化(LAA) AIS患者血管内取栓(EVT)的影响尚缺乏证据。目的:评价EVT术后LAA致AIS患者行IT治疗的安全性和有效性。方法:系统检索Pubmed、Embase、Cochrane Central Register of Controlled Trials和Web of Science数据库,检索入组接受IT治疗LAA所致AIS患者的研究。采用95% %置信区间的风险比(RR)和随机效应模型的Mantel-Haenszel方法进行统计学分析,评价疗效和安全性。采用I²统计量和Cochran Q检验评估异质性。该荟萃分析评估了0 - 2之间的改良Rankin量表(mRS)、再灌注成功、症状性颅内出血(siich)和90天内的死亡率。本研究采用R软件(4.4.1版)进行统计分析。结果:共分析8项研究,共纳入2607例患者。在荟萃分析中,IT组与更高比例的mRS 0-2相关(RR 1.16;95 % ci 1.04-1.29;I²= 0 %)。两组再灌注成功率无差异(RR 1.03;95 % ci 0.98-1.09;I²= 64.2 %)和siich (RR 0.83;95 % ci 0.55-1.26;I²= 22.9 %),尽管替罗非班与90天内较低的死亡率相关(RR 0.70;95 % ci 0.60-0.82;I²= 0 %)。结论:本荟萃分析强调了辅助IT对因LAA提交EVT的AIS患者的积极作用。它已被证明可以改善这一人群的功能结果和降低死亡率,是一种可靠的药物。
{"title":"Efficacy and safety of intravenous tirofiban in patients with acute ischemic stroke due to large artery atherosclerosis undergoing endovascular thrombectomy: A systematic review and meta-analysis","authors":"Ocílio Ribeiro Gonçalves ,&nbsp;Frederico de Sousa Marinho Mendes Filho ,&nbsp;Filipe Virgilio Ribeiro ,&nbsp;Saul Dominici ,&nbsp;Christian Ken Fukunaga ,&nbsp;Naysha Myllene de Lima Gonçalves ,&nbsp;Kenzo Ogasawara ,&nbsp;Rebeca Oliveira da Silva ,&nbsp;Kelson James Almeida","doi":"10.1016/j.clineuro.2025.108727","DOIUrl":"10.1016/j.clineuro.2025.108727","url":null,"abstract":"<div><h3>Introduction</h3><div>Intravenous tirofiban (IT) is shown to be potentially effective in acute ischemic stroke (AIS) patients submitted to mechanical thrombectomy, despite its safety and efficacy are not well established. However, there is a lack of evidence on the effects of IT on endovascular thrombectomy (EVT) in patients with AIS due to large artery atherosclerosis (LAA).</div></div><div><h3>Objectives</h3><div>To assess the safety and efficacy of IT in AIS patients due to LAA submitted to EVT.</div></div><div><h3>Methods</h3><div>Pubmed, Embase, Cochrane Central Register of Controlled Trials, and Web of Science databases were systematically searched for studies that involved patients enrolled to take IT in AIS caused by LAA. The statistical analysis was performed using Risk Ratio (RR) with 95 % confidence intervals and the Mantel-Haenszel method of random-effects model to evaluate both efficacy and safety. Heterogeneity was assessed using I² statistics and Cochran Q test. This meta-analysis evaluated a modified Rankin scale (mRS) between 0 and 2, successful reperfusion, symptomatic intracranial hemorrhage (sICH), and mortality in 90 days. The statistical analyses for this study were performed using R software (version 4.4.1.)</div></div><div><h3>Results</h3><div>A total of 8 studies were analyzed, and a total of 2607 patients were included. In the meta-analysis, the IT group was associated with a higher proportion of patients in mRS 0–2 (RR 1.16; 95 % CI 1.04–1.29; I² = 0 %). There was no difference between the groups regarding successful reperfusion (RR 1.03; 95 % CI 0.98–1.09; I² = 64.2 %) and sICH (RR 0.83; 95 % CI 0.55–1.26; I² = 22.9 %), although tirofiban was associated with a lower mortality in 90 days (RR 0.70; 95 % CI 0.60–0.82; I² = 0 %).</div></div><div><h3>Conclusion</h3><div>This meta-analysis highlights the positive effects of adjuvant IT for AIS patients due to LAA submitted to EVT. It has been shown to improve functional outcomes and lower mortality rates in this population and to be a reliable medication in this setting.</div></div>","PeriodicalId":10385,"journal":{"name":"Clinical Neurology and Neurosurgery","volume":"249 ","pages":"Article 108727"},"PeriodicalIF":1.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143000735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical value of serum LncRNA MIAT in early diagnosis and prognosis assessment of traumatic brain injury 血清LncRNA MIAT在创伤性脑损伤早期诊断及预后评估中的临床价值。
IF 1.8 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.clineuro.2024.108648
Zhiqiang Tang , Shuyun Xu , Shucheng Zhao , Zhihui Luo , Yuanli Tang , Yuanjun Zhang

Objective

This study aims to explore the clinical significance of long non-coding RNA, myocardial infarction-associated transcript (MIAT), in patients with traumatic brain injury (TBI).

Methods

Retrospective inclusion of TBI patients meeting clinical criteria with complete data, alongside healthy controls. RT-qPCR was used to detect the expression of the serum MIAT. Based on the Glasgow Coma Scale (GCS) scores, patients were categorized into mild, moderate, and severe TBI groups. The potential risk factors for severity were examined using logistic regression analysis. The one-year prognosis for TBI was determined using the Glasgow Outcome Scale (GOS) score. The correlation of MIAT levels with GCS scores and GOS scores was determined using Pearson correlation analysis. The effect of MIAT on the severity and poor prognosis was assessed using the receiver operating characteristic curve. Lastly, the dual-luciferase reporter assay confirmed the relationship between the MIAT and miR-221–3p.

Results

110 patients with TBI and 106 healthy controls were included. Serum MIAT levels were strikingly higher in patients with TBI compared to controls, whereas miR-221–3p levels were lower. As the severity of TBI increases, the expression of MIAT gradually elevated. A notable negative correlation was observed between serum MIAT levels and both the GCS and GOS scores. MIAT levels were effective in distinguishing patients with moderate TBI from those with mild or severe TBI, with a sensitivity of 82.35 % and 88.64 % and a specificity of 86.67 % and 86.27 %. Furthermore, elevated MIAT levels, with a sensitivity of 85.00 % and a specificity of 75.56 %, can predict the clinical outcomes of patients with TBI. miR-221–3p levels were negatively correlated with MIAT expression in patients with TBI, and MIAT directly targeted miR-221–3p.

Conclusion

Serum MIAT could serve as a diagnostic marker of severity and may predict poor prognosis in patients with TBI. This study proposes fresh perspectives on the pursuit of biomarkers and the management of patients with TBI.
目的:探讨长链非编码RNA心肌梗死相关转录物(MIAT)在创伤性脑损伤(TBI)患者中的临床意义。方法:回顾性纳入符合临床标准且数据完整的TBI患者,以及健康对照者。RT-qPCR检测血清MIAT的表达。根据格拉斯哥昏迷量表(GCS)评分,将患者分为轻度、中度和重度TBI组。使用logistic回归分析检查严重程度的潜在危险因素。使用格拉斯哥预后量表(GOS)评分确定TBI的一年预后。采用Pearson相关分析确定MIAT水平与GCS评分和GOS评分的相关性。采用受试者工作特征曲线评估MIAT对严重程度和不良预后的影响。最后,双荧光素酶报告试验证实了MIAT与miR-221-3p之间的关系。结果:纳入110例TBI患者和106例 健康对照。与对照组相比,TBI患者的血清MIAT水平显著高于对照组,而miR-221-3p水平较低。随着TBI严重程度的增加,MIAT的表达逐渐升高。血清MIAT水平与GCS和GOS评分呈显著负相关。MIAT水平可有效区分中度TBI患者与轻度或重度TBI患者,敏感性分别为82.35 %和88.64 %,特异性分别为86.67 %和86.27 %。此外,MIAT水平升高的敏感性为85.00 %,特异性为75.56 %,可以预测TBI患者的临床预后。TBI患者miR-221-3p水平与MIAT表达呈负相关,且MIAT直接靶向miR-221-3p。结论:血清MIAT可作为TBI患者病情严重程度的诊断指标,并可预测预后不良。这项研究为寻找生物标志物和TBI患者的治疗提供了新的视角。
{"title":"Clinical value of serum LncRNA MIAT in early diagnosis and prognosis assessment of traumatic brain injury","authors":"Zhiqiang Tang ,&nbsp;Shuyun Xu ,&nbsp;Shucheng Zhao ,&nbsp;Zhihui Luo ,&nbsp;Yuanli Tang ,&nbsp;Yuanjun Zhang","doi":"10.1016/j.clineuro.2024.108648","DOIUrl":"10.1016/j.clineuro.2024.108648","url":null,"abstract":"<div><h3>Objective</h3><div>This study aims to explore the clinical significance of long non-coding RNA, myocardial infarction-associated transcript (MIAT), in patients with traumatic brain injury (TBI).</div></div><div><h3>Methods</h3><div>Retrospective inclusion of TBI patients meeting clinical criteria with complete data, alongside healthy controls. RT-qPCR was used to detect the expression of the serum MIAT. Based on the Glasgow Coma Scale (GCS) scores, patients were categorized into mild, moderate, and severe TBI groups. The potential risk factors for severity were examined using logistic regression analysis. The one-year prognosis for TBI was determined using the Glasgow Outcome Scale (GOS) score. The correlation of MIAT levels with GCS scores and GOS scores was determined using Pearson correlation analysis. The effect of MIAT on the severity and poor prognosis was assessed using the receiver operating characteristic curve. Lastly, the dual-luciferase reporter assay confirmed the relationship between the MIAT and miR-221–3p.</div></div><div><h3>Results</h3><div>110 patients with TBI and 106 healthy controls were included. Serum MIAT levels were strikingly higher in patients with TBI compared to controls, whereas miR-221–3p levels were lower. As the severity of TBI increases, the expression of MIAT gradually elevated. A notable negative correlation was observed between serum MIAT levels and both the GCS and GOS scores. MIAT levels were effective in distinguishing patients with moderate TBI from those with mild or severe TBI, with a sensitivity of 82.35 % and 88.64 % and a specificity of 86.67 % and 86.27 %. Furthermore, elevated MIAT levels, with a sensitivity of 85.00 % and a specificity of 75.56 %, can predict the clinical outcomes of patients with TBI. miR-221–3p levels were negatively correlated with MIAT expression in patients with TBI, and MIAT directly targeted miR-221–3p.</div></div><div><h3>Conclusion</h3><div>Serum MIAT could serve as a diagnostic marker of severity and may predict poor prognosis in patients with TBI. This study proposes fresh perspectives on the pursuit of biomarkers and the management of patients with TBI.</div></div>","PeriodicalId":10385,"journal":{"name":"Clinical Neurology and Neurosurgery","volume":"249 ","pages":"Article 108648"},"PeriodicalIF":1.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142871561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Neurology and Neurosurgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1